Meshinchi S - Search Results

1

Disease Characteristics and Prognostic Implications of Cell-Surface FLT3 Receptor (CD135) Expression in Pediatric Acute Myeloid Leukemia: A Report from the Children's Oncology Group.

Tarlock K, Alonzo TA, Loken MR, Gerbing RB, Ries RE, Aplenc R, Sung L, Raimondi SC, Hirsch BA, Kahwash SB, McKenney A, Kolb EA, Gamis AS, Meshinchi S. Tarlock K, et al. Among authors: meshinchi s. Clin Cancer Res. 2017 Jul 15;23(14):3649-3656. doi: 10.1158/1078-0432.CCR-16-2353. Epub 2017 Jan 20. Clin Cancer Res. 2017. PMID: 28108543 Free PMC article.

2

Prevalence and prognostic significance of Flt3 internal tandem duplication in pediatric acute myeloid leukemia.

Meshinchi S, Woods WG, Stirewalt DL, Sweetser DA, Buckley JD, Tjoa TK, Bernstein ID, Radich JP. Meshinchi S, et al. Blood. 2001 Jan 1;97(1):89-94. doi: 10.1182/blood.v97.1.89. Blood. 2001. PMID: 11133746 Free article.

3

FLT3, RAS, and TP53 mutations in elderly patients with acute myeloid leukemia.

Stirewalt DL, Kopecky KJ, Meshinchi S, Appelbaum FR, Slovak ML, Willman CL, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Blood. 2001 Jun 1;97(11):3589-95. doi: 10.1182/blood.v97.11.3589. Blood. 2001. PMID: 11369655 Free article.

4

Comparison of multidimensional flow cytometry with standard morphology for evaluation of early marrow response in pediatric acute lymphoblastic leukemia.

Meshinchi S, Thomson B, Finn LS, Leisenring W, Green C, Radich JP, Loken M, Hawkins D. Meshinchi S, et al. J Pediatr Hematol Oncol. 2001 Dec;23(9):585-90. doi: 10.1097/00043426-200112000-00007. J Pediatr Hematol Oncol. 2001. PMID: 11902302

5

Molecular targets in acute myelogenous leukemia.

Stirewalt DL, Meshinchi S, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Blood Rev. 2003 Mar;17(1):15-23. doi: 10.1016/s0268-960x(02)00057-7. Blood Rev. 2003. PMID: 12490207 Review.

6

Activating mutations of RTK/ras signal transduction pathway in pediatric acute myeloid leukemia.

Meshinchi S, Stirewalt DL, Alonzo TA, Zhang Q, Sweetser DA, Woods WG, Bernstein ID, Arceci RJ, Radich JP. Meshinchi S, et al. Blood. 2003 Aug 15;102(4):1474-9. doi: 10.1182/blood-2003-01-0137. Epub 2003 Apr 17. Blood. 2003. PMID: 12702504 Free article.

7

FLT3 internal tandem duplication in 234 children with acute myeloid leukemia: prognostic significance and relation to cellular drug resistance.

Zwaan CM, Meshinchi S, Radich JP, Veerman AJ, Huismans DR, Munske L, Podleschny M, Hählen K, Pieters R, Zimmermann M, Reinhardt D, Harbott J, Creutzig U, Kaspers GJ, Griesinger F. Zwaan CM, et al. Among authors: meshinchi s. Blood. 2003 Oct 1;102(7):2387-94. doi: 10.1182/blood-2002-12-3627. Epub 2003 Jun 19. Blood. 2003. PMID: 12816873 Free article.

8

Prognostic factors and risk-based therapy in pediatric acute myeloid leukemia.

Meshinchi S, Smith FO, Arceci RJ. Meshinchi S, et al. Curr Oncol Rep. 2003 Nov;5(6):489-97. doi: 10.1007/s11912-003-0010-1. Curr Oncol Rep. 2003. PMID: 14521808 Review.

9

Survival after second hematopoietic stem cell transplantation for recurrent pediatric acute myeloid leukemia.

Meshinchi S, Leisenring WM, Carpenter PA, Woolfrey AE, Sievers EL, Radich JP, Sanders JE. Meshinchi S, et al. Biol Blood Marrow Transplant. 2003 Nov;9(11):706-13. doi: 10.1016/j.bbmt.2003.08.003. Biol Blood Marrow Transplant. 2003. PMID: 14652854 Free article.

10

Novel FLT3 point mutations within exon 14 found in patients with acute myeloid leukaemia.

Stirewalt DL, Meshinchi S, Kussick SJ, Sheets KM, Pogosova-Agadjanyan E, Willman CL, Radich JP. Stirewalt DL, et al. Among authors: meshinchi s. Br J Haematol. 2004 Feb;124(4):481-4. doi: 10.1111/j.1365-2141.2004.04808.x. Br J Haematol. 2004. PMID: 14984498 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

255 results

Search Page